OptiLight Intense Pulse Light (IPL) (Background)

Eyelid inflammation (blepharitis) is a major cause of meibomian gland dysfunction (MGD) and evaporative dry eye disease, one of the most frequent and less well managed diseases in eye care.

There is a clear association between eyelid inflammation and skin inflammation around the periorbital region. In particular, skin rosacea leads to eyelid inflammation in 80% of the cases: patients with skin rosacea are 3-4 times more likely to suffer from eyelid inflammation and MGD. Some common characteristics or features of these conditions include erythema, telangiectasia of the conjunctiva or eyelid margin, watery or bloodshot eyes. It is well accepted that abnormal blood vessels secrete pro-inflammatory substances. Due to the close proximity, these pro-inflammatory agents reach the eyelids via the orbital vasculature. The exposure of the eyelids to these inflammatory agents can trigger blepharitis and, subsequently, meibomian gland dysfunction and ocular rosacea. 

One of the most effective tools to reduce eyelid inflammation and associated ocular complications is by treating the skin around and close to the periorbital region with OptiLight Intense Pulse Light (IPL). Mainly treating the skin below the lower eyelids, IPL destroys abnormal blood vessels and, thus, removes a major source of inflammation to the eyelids.